PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q4 2023 Earnings Call Transcript February 28, 2024 PROCEPT BioRobotics Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. Welcome to the Q4 2023 PROCEPT BioRobotics Earnings Conference […]
PROCEPT BioRobotics Corporation revised earnings guidance for the year 2023. The Company projects revenue for the full year 2023 to be $128 million, which represents 71% growth over the Company s. | April 28, 2023
IPO vor genau einem Jahr. Procept BioRobotics (PRCT) entwickelt und produziert Robotor für die urologische Chirurgie. Börsentäglich coole Setups im Traders Live Chat bei ratgeberGEDL.at
Symbol: PRCT ISIN: